Core Insights - WeightWatchers has expanded its collaboration with Novo Nordisk to provide members with access to FDA-approved Wegovy® at a reduced price of $299, effective July 1, 2025, offering a $200 savings [1][3] - The partnership aims to enhance patient outcomes through a holistic model that combines medication access with WeightWatchers' nutrition and behavioral support programs [4][7] - Wegovy® is the only FDA-approved semaglutide treatment for weight loss, currently supporting nearly 1.5 million patients in the U.S., and has been shown to deliver significant weight loss results when combined with WeightWatchers' support [5][7] Company Overview - WeightWatchers is recognized as a global leader in science-backed weight management, focusing on long-term weight health and prescribing only FDA-approved medications [1][8] - The company emphasizes a holistic approach that integrates clinical interventions, community support, and a trusted weight-loss program [8] Collaboration Details - The collaboration includes a simplified prescription process through NovoCare® Pharmacy, which will facilitate home delivery of Wegovy® prescriptions for WeightWatchers Clinic members [2] - WeightWatchers and Novo Nordisk plan to explore real-world research initiatives to evaluate the impact of combining Wegovy® with WeightWatchers' support programs on long-term health outcomes [4][5] Market Position - WeightWatchers positions itself as a trusted leader in a market filled with unapproved and unsafe weight management options, focusing on evidence-based care and patient safety [4][5] - The company aims to set the standard for responsible weight management by combining access to safe medications with comprehensive lifestyle support [4]

Core Insights - CheqUp and WeightWatchers have formed a partnership to provide a comprehensive weight management solution that combines GLP-1 medication with behavioral support [1][2][3] - The partnership aims to address the increasing demand for effective weight loss solutions in the UK, where 12 million people qualify for GLP-1 medications [3][4] - WeightWatchers' GLP-1 Companion Programme is designed to enhance the effectiveness of weight loss through structured support, showing that participants lose 11% more weight on average when combining medication with behavioral programs [4][6] Company Overview - CheqUp is recognized as a leading provider of medically supervised weight loss programs, offering personalized treatment plans and clinical oversight [9] - WeightWatchers has over 60 years of experience in weight management, utilizing a science-backed model that has helped members achieve significant weight loss results [8][10] Partnership Details - The partnership will provide CheqUp members with access to WeightWatchers' GLP-1 Companion Programme at no additional cost, enhancing their weight loss journey [5][6] - The program includes nutritional guidance, tracking tools, social support networks, and progress monitoring to facilitate sustainable weight loss [7][8]

Summary of Financial Reorganization Plan May 6, 2025 Strategic Action to Eliminate $1.15 Billion of Debt and Strengthen Financial Position The decisive actions we're taking today, with the overwhelming support of our lenders and noteholders, will give us the flexibility to accelerate innovation, reinvest in our members, and lead with authority in a rapidly evolving weight management landscape. As the $1.6B Existing $465M Pro forma ~70% Reduction Debt conversation around weight shifts toward long- term healt ...

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2][3] - The company specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Company Performance - WW International reported a quarterly loss of $0.47 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.26, and compared to a loss of $0.06 per share a year ago, indicating an earnings surprise of -80.77% [1] - The company posted revenues of $186.57 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.63%, and down from $206.55 million in the same quarter last year [2] - WW International shares have declined approximately 44.1% since the beginning of the year, contrasting with the S&P 500's decline of -3.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.05 on revenues of $190.75 million, and for the current fiscal year, it is -$0.21 on revenues of $767.49 million [7] - The estimate revisions trend for WW International is currently favorable, leading to a Zacks Rank 1 (Strong Buy) for the stock, suggesting expected outperformance in the near future [6] Industry Context - The Leisure and Recreation Services industry, to which WW International belongs, is currently ranked in the bottom 27% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Summary of Weight Watchers Investor Conference Call (May 06, 2025) Company Overview - **Company**: Weight Watchers International (WW) - **Event**: Investor Conference Call discussing Q1 2025 results and financial reorganization Key Points Financial Reorganization - Weight Watchers has entered a voluntary prepackaged Chapter 11 process to restructure its capital [2][20] - An agreement has been reached with a super majority of lenders to reduce debt by **$1,150,000,000**, a reduction of over **70%** from current levels [6][20] - Long-term debt will decrease from **$1,600,000,000** to **$465,000,000**, with maturities extended to **2030** [6][20] - Anticipated annual interest payments will be halved to approximately **$50,000,000**, improving free cash flow [6][20] - Cash balance at the end of Q1 was **$236,000,000**, including **$171,000,000** from a revolving credit facility drawdown [7][26] Operational Continuity - Weight Watchers remains fully operational during the reorganization, with no impact on services or member plans [9] - All trade creditors and general unsecured creditors will be paid in full [9] Subscriber and Revenue Trends - Total subscribers declined **14%** year-over-year to **3,400,000**, but clinical subscriber growth accelerated by **47%** to **135,000** [21][22] - Q1 revenue was **$187,000,000**, a **10%** decline year-over-year, with clinical revenue growing **57%** to **$29,000,000** [23] - Adjusted gross margin reached a record high of **71%**, up from **67.9%** in the prior year [23] Strategic Focus - The company aims to stabilize and innovate to lay the groundwork for future growth [27] - Weight Watchers emphasizes a holistic approach to weight management, integrating clinical care with behavioral support [12][15] - The company plans to transition clinic members from compounded semaglutide to other medications by May 22, 2025, due to FDA regulations [28] Market Position and Community Engagement - Weight Watchers is recognized as a leader in the weight management industry, with a strong legacy of scientific backing and community support [11][17] - The company highlights the importance of community in achieving weight loss goals, noting that workshop members lose twice as much weight as those who do it alone [17] Future Outlook - Weight Watchers expects continued revenue headwinds in 2025, particularly in the behavioral business, but remains confident in long-term growth potential [29] - The company is focused on operational improvements and disciplined capital allocation to balance profitability with growth [29] Conclusion - Weight Watchers is committed to its transformation and innovation strategy, aiming to emerge from the reorganization as a stronger, publicly traded company [9][20][32]

Core Viewpoint - WW International, Inc. is undergoing a financial reorganization to eliminate $1.15 billion in debt, enhance its digital and member experience, and expand its telehealth business, which saw a 57% year-over-year revenue growth in Q1 2025 [1][3][4] Financial Reorganization - The company has entered into a comprehensive agreement with lenders and noteholders, representing approximately 72% of the outstanding principal amount of its term loan and credit facilities, to support the reorganization [3] - The reorganization is expected to be confirmed in about 40 to 45 days, allowing the company to emerge as a publicly traded entity [1][3] - The transaction will reduce annual interest expenses by approximately $50 million and extend the maturity of its debt [6] Operational Continuity - WeightWatchers remains fully operational during the reorganization process, ensuring no impact on its more than three million members worldwide [1][2] - The company will continue to honor all commitments to employees, vendors, and creditors, paying all trade creditors in full [2][5] Strategic Growth Initiatives - The reorganization will provide the company with increased investment flexibility to accelerate innovation and reinvest in member services [4] - The focus will be on enhancing the digital experience and expanding the telehealth business, which has shown significant revenue growth [1][4] Stakeholder Communication - WeightWatchers has launched a dedicated webpage for members to access information about the restructuring process [4] - Stakeholders can contact the company's claims agent for additional information regarding the court-supervised process [7]

Core Viewpoint - WW International, Inc. is expected to announce a significant reduction in debt obligations through an agreement with lenders and noteholders, leading to a voluntary prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code [1] Company Overview - WW International, Inc. is recognized as the global leader in science-backed weight management, offering a holistic model of care through its Points® Program, clinical interventions, and community support [2] - The company has been empowering millions of members since 1963 to build healthy habits and sustain their weight management goals [2]

Exhibit 99.1 WW International, Inc. Announces First Quarter 2025 Results NEW YORK (May 6, 2025) – WW International, Inc. (NASDAQ: WW) ("WeightWatchers," "WW," or the "Company") today announced its results for the first quarter of fiscal 2025 ended March 29, 2025. "We are making progress on our strategic priorities with continued momentum in our Clinical business, while laying the foundation for long-term, sustainable growth," said Tara Comonte, President and CEO. "As the weight management landscape evolves, ...

Core Insights - WW International, Inc. reported a net loss of $72.6 million for Q1 2025, a significant improvement from a net loss of $347.9 million in the same period last year, reflecting a 79.1% reduction in losses [9][10][16] - The company experienced a 9.7% decline in total revenues, amounting to $186.6 million, primarily due to challenges in the Behavioral business, despite a 57% year-over-year growth in Clinical revenue [3][10][9] - Adjusted EBITDAS increased to $26.9 million, up 274% year-over-year, indicating improved operational efficiency and cost management [9][10][16] Financial Performance - Subscription revenues decreased by 9.3% to $185.2 million, with Clinical subscription revenues rising by 57.1% to $29.5 million [3][10][9] - Gross profit was $132.9 million, down 3.6% from the previous year, while the gross margin improved to 71.2%, up 450 basis points [9][10][16] - The company reported an adjusted EPS of -$0.47, compared to -$1.29 in the prior year, marking a 63.7% improvement [9][10][16] Subscriber Metrics - Total end-of-period subscribers decreased by 14.2% to 3.4 million, with a notable 55.2% increase in Clinical subscribers to 135,000 [9][10][10] - Digital subscribers fell by 14.7% to 2.8 million, while Workshops + Digital subscribers decreased by 21.1% to 0.5 million [9][10][10] - Subscription revenues per paid week increased by 4.8% to $4.13, driven by growth in the Clinical business [9][10][10] Strategic Initiatives - The company is focusing on delivering a unified member experience, revitalizing its brand, and expanding adjacent revenue streams [2][10] - WW International is engaged in discussions with lenders to restructure its capital and reduce debt, with a potential prepackaged filing under Chapter 11 anticipated imminently [9][10][16] - The management emphasizes the importance of operational excellence and efficiency to stabilize the business and return to growth [2][10]